In 2023, Rohto Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Rohto Pharmaceutical generated a total of 2,567 metric tonnes of waste.
Of this amount, 72.69% of Rohto Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 27.31% was disposed of through landfilling, incineration, or combustion.
In 2023, Rohto Pharmaceutical reported a total waste generation of 2,567 metric tonnes, of which 72.69% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Rohto Pharmaceutical is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Since 2019, Rohto Pharmaceutical's total waste generation decreased by 6.52%, yet rose by 4.52% in 2023, potentially indicating a temporary operational shift or inconsistency in waste management outcomes.
Over the same period, Rohto Pharmaceutical's waste recovery rate increased by 18.06%.